LD-2 disclosure · 3rd Quarter - Report
INNOVATIVE VACCINE TECHNOLOGIES
Coverage · No income or expenses were reported on this filing.
Client
- Description
- Bio tech company
- Location
- Utah · United States of America
Registrant
- Description
- Government and Public Relations consultants
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
2 issuesMedical/Disease Research/Clinical Labs
FY2026 appropriations for the development of a synthetic vaccine
LobbyistsROBERT L LIVINGSTON · J ALLEN MARTIN
Budget/Appropriations
FY2026 appropriations for the development of a synthetic vaccine
LobbyistsROBERT L LIVINGSTON · J ALLEN MARTIN